SLQT SelectQuote, Inc.

CIK 0001794783 45 ready 8-Ks latest May 5, 2026, 7:59 PM ET RSS · JSON

Activity: QUIET 0 filings / 30d vs 1 baseline

Ready 8-Ks 45

Latest filing May 5, 2026, 7:59 PM ET

Top materiality 0.90

Event mix earnings ×22 · other_material ×11 · debt ×5

Sentiment 17 pos · 11 neg · 17 neu

Latest earnings reported 2026-Q3

Executive change recent →

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for SLQT

Highest-materiality recent filing

SelectQuote reports Q4 net loss of $104.7M on $139.4M revenue; cuts revolver by $35M, issues weak FY2023 guidance

August 29, 2022, 7:59 PM ET earnings materiality 0.90 negative item 1.01 item 2.02 item 2.03 item 9.01

Q4 FY2022 revenue $139.4M (down 25% YoY), net loss $104.7M vs prior year net income $0.8M, adjusted EBITDA -$60.8M.
Includes $48.3M cohort/tail adjustment; ex-adjustment revenue $187.7M, adjusted EBITDA -$12.5M.

Read filing →

May 5, 2026, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01 ◈ Earnings Releases

SelectQuote Q3 FY2026 revenue $430.9M, net income $40.2M, reaffirms FY guidance

Revenue $430.9M (up from $408.2M YoY); net income $40.2M vs $26.0M.
March 25, 2026, 7:59 PM ET other material materiality 0.75 negative item 3.01 item 7.01 item 9.01 ◈ Listing & Compliance Notices

SelectQuote stock price below $1.00 triggers NYSE non-compliance notice; cure period six months

NYSE notice: avg closing price <$1.00 over 30 consecutive trading days; six-month cure period to regain compliance.
February 5, 2026, 6:59 PM ET earnings materiality 0.80 neutral item 2.02 item 9.01

SelectQuote Q2 revenue $537M, net income $69.3M; cuts FY guidance on carrier, PBM headwinds

Revenue $537.1M vs $481.1M YoY; net income $69.3M vs $53.2M; Adj. EBITDA $84.7M vs $87.5M.
January 12, 2026, 6:59 PM ET debt materiality 0.75 positive item 1.01 item 1.02 item 2.03 item 7.01 item 9.01 ◈ Debt Financings ×2◈ Material Agreements ×2

SelectQuote closes $415M credit facility with Pathlight and UMB, extends maturity to 2031

New $325M term loan (Pathlight) and $90M revolver (UMB) replace prior facilities; $313.8M used to repay existing debt.
November 6, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

SelectQuote Q1 FY2026 revenue $328.8M, net loss narrows to $30.5M but adj EBITDA plunges to -$32.1M

Revenue $328.8M vs $292.3M YoY; net loss $30.5M vs $44.5M YoY.
August 21, 2025, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

SelectQuote reports Q4 revenue $345.1M, net income $12.9M; FY26 revenue guidance $1.65B-$1.75B

Revenue $345.1M (+12% YoY); net income $12.9M vs net loss $31.0M in Q4 FY2024.
August 21, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

SelectQuote Q4 FY2025 revenue up 12% to $345M; net income of $12.9M vs prior year loss

Revenue $345.1M (+12% YoY); net income $12.9M vs net loss -$31.0M in Q4 FY2024.
July 2, 2025, 7:59 PM ET leadership materiality 0.65 negative item 8.01 item 9.01

SelectQuote Vice Chairman Tom Grant dies; sons Bill and Bob remain in executive roles

William T. (Tom) Grant II, Vice Chairman and former President, passed away July 1, 2025 after a battle with cancer.
May 12, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

SelectQuote Q3 revenue $408.2M, net income $26.0M; guides FY25 EBITDA $115M-$140M

Revenue $408.2M (+8.5% YoY); net income $26.0M vs $8.6M YoY.
February 28, 2025, 6:59 PM ET debt materiality 0.80 neutral item 1.01 item 3.02 item 5.03 item 3.03 item 5.02 item 9.01 ◈ executive_change ×2◈ Governance Changes

SelectQuote closes $350M preferred stock and warrant investment from Morgan Stanley and Bain Capital

Morgan Stanley and Bain each invested $175M for 175,000 preferred shares and warrants in three tranches on Feb 28, 2025.
February 10, 2025, 6:59 PM ET other material materiality 0.85 neutral item 1.01 item 2.02 item 2.03 item 3.02 item 3.03 item 7.01 item 9.01

SelectQuote raises $350M via preferred stock, reports Q2 net income $53.2M

$350M aggregate investment from Morgan Stanley and Bain in Senior Non-Convertible Preferred Stock and warrants.
November 4, 2024, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

SelectQuote Q1 FY2025 revenue $292.3M, net loss $44.5M, Adj EBITDA $(1.7)M

Revenue of $292.3M, up 26% YoY from $232.7M; net loss widened to $44.5M from $31.1M.
October 18, 2024, 7:59 PM ET debt materiality 0.60 neutral item 1.01 item 2.03 item 9.01

SelectQuote subsidiary issues $100M in asset-backed notes secured by commissions

$60M Class A 7.80% notes and $40M Class B 9.65% notes issued by subsidiary SQ ABS Issuer, LLC.
October 16, 2024, 7:59 PM ET other material materiality 0.75 positive item 1.01 item 2.03 item 3.02 item 7.01 item 9.01

SelectQuote completes $100M securitization, extends term debt maturity to Sept 2027

Issued $60M of 7.80% Class A notes and $40M of 9.65% Class B notes in ABS facility.
September 13, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

SelectQuote Q4 FY2024 revenue $307M, Adj EBITDA $14.4M; FY2025 Adj EBITDA guidance $90-120M

Q4 revenue $307.2M (up from $221.8M YoY); net loss narrowed to $31.0M from $47.8M.
May 9, 2024, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01 ◈ Earnings Releases

SelectQuote Q3 revenue up 26% YoY to $376M; raises FY2024 guidance

Revenue $376.4M vs $299.4M YoY; net income $8.6M vs $9.3M YoY.
February 7, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

SelectQuote Q2 revenue rises 27% to $405.4M; raises full-year guidance

Revenue $405.4M, up 27% YoY from $319.2M; net income $19.4M vs $22.5M YoY.
November 2, 2023, 7:59 PM ET earnings materiality 0.70 neutral item 2.02 item 9.01 ◈ Earnings Releases

SelectQuote Q1 FY2024 revenue $232.7M, net loss narrows to $31.1M; reaffirms FY guidance

Revenue $232.7M (+43% YoY); net loss $31.1M vs $42.5M; Adj EBITDA -$11.4M vs -$27.5M.
September 13, 2023, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

SelectQuote Q4 FY2023 revenue $221.8M, net loss narrows to $47.8M; FY2024 Adj EBITDA guidance $80M-$105M

Q4 revenue $221.8M (up 59% YoY); net loss $47.8M (improved from $104.7M loss).
May 12, 2023, 7:59 PM ET earnings materiality 0.65 negative item 2.02 item 9.01 ◈ Earnings Releases

SelectQuote corrects FY2023 net loss guidance upward; previously understated

Corrected FY2023 net loss guidance now $73M-$55M (previously understated).
May 10, 2023, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 7.01 item 9.01 ◈ Earnings Releases

SelectQuote Q3 FY2023 rev $299.4M, net income $9.3M; raises FY2023 Adj EBITDA guidance

Q3 revenue $299.4M vs $274.3M YoY; net income $9.3M vs loss of $7.0M.
March 2, 2023, 6:59 PM ET other material materiality 0.60 positive item 8.01 item 9.01

SelectQuote regains NYSE compliance as stock price rises above $1.00

Received NYSE notice on March 1, 2023 that it cured stock price deficiency; share price and 30-day average above $1.00 as of Feb 28, 2023.
February 22, 2023, 6:59 PM ET leadership materiality 0.60 neutral item 5.02 item 8.01 item 9.01 ◈ executive_change

SelectQuote names Ryan Clement permanent CFO; base salary $375K, annual equity target $800K

Ryan Clement, interim CFO since May 2022, appointed permanent CFO effective Feb 10, 2023.
February 7, 2023, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 7.01 item 9.01 ◈ Earnings Releases

SelectQuote posts Q2 revenue $319.2M, net income $22.5M; raises FY23 EBITDA guidance midpoint $20M

Revenue $319.2M vs $194.2M YoY; net income $22.5M vs net loss $137.6M.
January 5, 2023, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

SelectQuote prelim Q2 rev $300-320M, raises FY23 guidance above prior ranges

Q2 FY2023 prelim revenue $300-320M; net income $11-23M; Adj. EBITDA $45-60M.
December 2, 2022, 6:59 PM ET other material materiality 0.65 negative item 8.01 item 9.01

SelectQuote announces special meeting to approve reverse stock split; record date Jan 11

Special meeting on March 2, 2023 to vote on reverse stock split amendment.
November 3, 2022, 7:59 PM ET earnings materiality 0.65 positive item 2.02 item 9.01 ◈ Earnings Releases

SelectQuote reports Q1 FY2023 revenue $162.5M, net loss $42.5M; reaffirms guidance

Revenue of $162.5M vs $156.1M YoY; net loss narrowed to $42.5M from $48.2M YoY.
October 26, 2022, 7:59 PM ET regulatory materiality 0.75 negative item 3.01 item 7.01 item 9.01

SelectQuote receives NYSE deficiency notice for sub-$1.00 stock price; 6-month cure period begins

NYSE notice on Oct 20, 2022: average closing price below $1.00 over 30 consecutive trading days.
August 29, 2022, 7:59 PM ET earnings materiality 0.90 negative item 1.01 item 2.02 item 2.03 item 9.01

SelectQuote reports Q4 net loss of $104.7M on $139.4M revenue; cuts revolver by $35M, issues weak FY2023 guidance

Q4 FY2022 revenue $139.4M (down 25% YoY), net loss $104.7M vs prior year net income $0.8M, adjusted EBITDA -$60.8M.
May 19, 2022, 7:59 PM ET leadership materiality 0.65 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change ×3

SelectQuote CFO Raff Sadun resigns; Ryan Clement named interim CFO

Sadun to depart June 1, 2022, to pursue opportunity outside insurance/healthcare; no disagreement with company.
May 5, 2022, 7:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

SelectQuote Q3 revenue $275.1M, net loss $6.4M; Senior segment adjusted EBITDA down 57% YoY

Revenue $275.1M vs $265.3M prior year; net loss $6.4M vs net income $35.2M.
February 7, 2022, 6:59 PM ET earnings materiality 0.85 negative item 2.02 item 9.01

SelectQuote Q2 FY2022 net loss $137M; adj EBITDA $(163)M; cuts FY guidance

Revenue $195M vs $357.6M YoY; net loss $137M vs net income $89.9M YoY.
November 4, 2021, 7:59 PM ET earnings materiality 0.75 negative item 1.01 item 2.02 item 2.03 item 9.01

SelectQuote Q1: revenue up 29% to $159.9M, net loss $45.4M; secured $200M debt facility

Revenue $159.9M, +29% YoY; net loss $45.4M vs $0.8M net income YoY.
October 26, 2021, 7:59 PM ET other material materiality 0.60 positive item 7.01 item 9.01

SelectQuote partners with Ready Responders for in-home healthcare services

Population Health will educate members on Ready Responders' non-emergency in-home care to reduce ER visits.
August 25, 2021, 7:59 PM ET earnings materiality 0.80 neutral item 2.02 item 9.01

SelectQuote Q4 rev up 33% to $188.4M, net income down $16.7M, adj EBITDA down 47%

Q4 net income $3.3M ($16.7M decrease YoY); FY net income $131.0M, up $49.9M.

Executive changes

Appointed

Srdjan Vukovic

Class II Director

SLQT · SelectQuote, Inc.

Effective: 2025-02-28
Filed: February 28, 2025, 6:59 PM ET

Srdjan Vukovic was appointed as a Class II Director

Appointed

Christopher Wolfe

Class I Director

SLQT · SelectQuote, Inc.

Effective: 2025-02-28
Filed: February 28, 2025, 6:59 PM ET

Christopher Wolfe was appointed as a Class I Director

Appointed

Ryan M. Clement

Chief Financial Officer

SLQT · SelectQuote, Inc.

Effective: 2023-02-10
Filed: February 22, 2023, 6:59 PM ET

On February 9, 2023, the Board of Directors of SelectQuote, Inc. (the “Company”) appointed Ryan M. Clement, 42, to serve as the Company’s Chief Financial Officer, effective February 10, 2023.

Appointed

Stephanie D. Fisher

principal accounting officer

SLQT · SelectQuote, Inc.

Effective: 2022-06-01
Filed: May 19, 2022, 7:59 PM ET

Also effective as of June 1, 2022, the Board designated Stephanie D. Fisher as the Company’s principal accounting officer.

Appointed (interim)

Ryan M. Clement

interim Chief Financial Officer

SLQT · SelectQuote, Inc.

Effective: 2022-06-01
Filed: May 19, 2022, 7:59 PM ET

Effective as of June 1, 2022, the Board appointed Ryan M. Clement, 41, to serve as the Company’s interim Chief Financial Officer pending a comprehensive national search for Mr. Sadun’s successor.

Departed

Raffaele Sadun

Chief Financial Officer

SLQT · SelectQuote, Inc.

Effective: 2022-06-01
Successor: Ryan M. Clement
Filed: May 19, 2022, 7:59 PM ET

On May 16, 2022, Raffaele Sadun notified the Board of Directors (the “Board”) of SelectQuote, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Financial Officer effective June 1, 2022 to pursue another career opportunity outside the insurance distribution and healthcare industries.

Role change

Robert Grant

President

SLQT · SelectQuote, Inc.

Effective: 2021-10-28
Filed: October 14, 2021, 7:59 PM ET

On October 14, 2021, SelectQuote, Inc. (the “Company”) announced the appointment of Robert Grant, 37, as the President of the Company, effective October 28, 2021 (the “Effective Date”).

Earnings & guidance

2026-Q3 EPS reported $0.11 filing →

Materiality & sentiment trend

Max materiality 0.90 · Median 0.75 · Most common event earnings

17 positive 11 negative 17 neutral

source · SLQT on sec.gov